Study on liposomalization of zinc-coproporphyrin I as a novel drug in photodynamic therapy

International Journal of Pharmaceutics

Volumn 338, Issue 1-2, 2007, Pages 306-309

  Sadzuka, Yasuyuki ^a   Iwasaki, Fumiaki ^a   Sugiyama, Ikumi ^a   Horiuchi, Kentaro ^b   Hirano, Toru ^b   Ozawa, Hidechika ^b   Kanayama, Naohiro ^b   Sonobe, Takashi ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Liposome; Photodynamic therapy (PDT); Photofrin; Zinc coproporphyrin I

Indexed keywords

BUFFER; COPROPORPHYRIN; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG; ZINC COMPLEX; ZINC COPROPORHYRIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG SOLUBILITY; DRUG STRUCTURE; EHRLICH ASCITES TUMOR; IN VIVO STUDY; LIPOSOMAL DELIVERY; MOUSE; NONHUMAN; PARTICLE SIZE; PH; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; ZETA POTENTIAL;

ANIMALS; CARCINOMA, EHRLICH TUMOR; COPROPORPHYRINS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; MALE; MICE; PHOTOCHEMISTRY; PHOTOCHEMOTHERAPY; TISSUE DISTRIBUTION;

EID: 34248642577     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.02.003     Document Type: Article

References (13)

1. Amemiya T., Nakajima T., and Katoh T. Photodynamic therapy of atherosclerosis using YAG-OPO laser and Porfilmer sodium and comparison with using argon-dye laser. Jpn. Circ. J. 63 (1999) 228-295
2. Bangham A.D., Standish M.M., and Watkins J.C. Diffusion of univalent ion across the lamellae of swollen phospholipids. J. Mol. Biol. 13 (1965) 238-252
3. Bellnier D.A., and Dougherty T.J.A. Preliminary pharmacokinetic study of intravenous photofrin in patients. J. Clin. Laser Med. Surg. 14 (1996) 311-314
4. Blumenkranz M.S., Bressler N.M., and Bressler S.B. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration. Arch. Ophthalmol. 120 (2002) 1307-1314
5. Bonnett R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem. Soc. Rev. 24 (1995) 19-33
6. Hirano T. The present condition of the laser for PDT. J. Jpn. Soc. Laser Surg. Med. 21 (1991) 129-135
7. Hisazumi H. The photodynamic therapy in a urology department domain. J. Jpn. Soc. Laser Surg. Med. 8 (1987) 11-14
8. Horiuchi K., Adachi K., Fujise Y., Naruse H., Sumimoto K., Kanayama N., and Terao T. Isolation and characterization of zinc-coproporphyrin I: a major fluorescent component in meconium. Clin. Chem. 37 (1991) 1173-1177
9. Itou K., Kano T., and Kobayashi S. The photodynamic therapy over endoscope-early stomach cancer. Biotherapy 5 (1991) 546-551
10. Jenkins M.P., Buonaccorsi G.A., and Raphael M. Clinical study of adjuvant photodynamic therapy to reduce restenosis following femoral angioplasty. Br. J. Surg. 86 (1999) 1258-1263
11. Kato H., Takahasi H., Konaka T., Ishii M., and Miura T. The photodynamic therapy of lung cancer. Biotherapy 5 (1991) 536-545
12. Obana A., Gohto Y., and Kaneda K. Selective occlusion of choroidal neovascularization by photodynamic therapy with a water-soluble photosensitizer, ATX-S10. Lasers Surg. Med. 24 (1999) 209-222
13. Sadzuka Y., Tokutomi K., Iwasaki F., Hirano T., Konno H., Oku N., and Sonobe T. The phototoxicity of photofrin was enhanced by PEGylated liposome in vitro. Cancer Lett. 241 (2006) 42-48